TotalEnergies posts 21% drop in annual profit, targets $2 billion of buybacks per quarter this year

TotalEnergies posts 21% drop in annual profit, targets  billion of buybacks per quarter this year


Poster and logo on the Coupole Tower, compagny Total’s head office renamed TotalEnergies in 2021 in the La Defense business district west of Paris in Courbevoie, France on 7 June 2024.

Antoine Boureau | Afp | Getty Images

French oil major TotalEnergies on Wednesday reported a sharp drop in full-year earnings, against a backdrop of lower crude prices and weak fuel demand.

The oil and gas giant posted full-year 2024 adjusted net income of $18.3 billion, reflecting a 21% fall from $23.2 billion a year earlier.

Analysts had expected TotalEnergies’ full-year 2024 adjusted net income to come in at $18.2 billion, according to an LSEG-compiled consensus.

The energy major reported better-than-expected fourth-quarter adjusted net income of $4.4 billion, an 8% increase on the previous quarter.

TotalEnergies said it was able to close out the year on a positive note thanks to a strong performance in integrated liquefied natural gas and integrated power.

The results buck a trend of consecutive quarterly losses. TotalEnergies’ adjusted net income had dropped for five straight quarters to notch a three-year low in September last year.

In a trading update published last month, TotalEnergies said its fourth-quarter results would likely benefit from a slight increase in hydrocarbon production, stronger gas trading and a modest increase in refining margins.

TotalEnergies announced a 7% increase in the 2024 dividend to 3.22 euros ($3.35) per share and said it will target $2 billion of share buybacks per quarter in 2025.

The company said it expects higher gas prices and robust hydrocarbon production in the first three months of 2025.

Paris-listed shares of TotalEnergies are up around 6.8% year-to-date.

The world’s top oil and gas companies have seen profits fall from record levels in 2022, when Russia’s full-scale invasion of Ukraine prompted international benchmark Brent crude to jump to nearly $140 per barrel.

Oil prices have since cooled amid faltering global demand, with Brent crude futures averaging $80 per barrel in 2024 — about $2 per barrel less than during the previous year, according to the U.S. Energy Information Administration.

Energy giants have reported mixed fourth-quarter and full-year results amid weaker refining margins and lower crude prices.

U.S. oil giant Exxon Mobil beat Wall Street’s estimate for fourth-quarter profit last week, while U.S. oil producer Chevron and Britain’s Shell both missed analyst forecasts.

This is breaking news. Please refresh for updates.



Source

Trump says India will stop buying Russian oil. Shadow fleet vessels are still unloading sanctioned crude at its ports
World

Trump says India will stop buying Russian oil. Shadow fleet vessels are still unloading sanctioned crude at its ports

The oil tanker “Grinch” (R), suspected of belonging to the Russian’s shadow fleet, is seen outside the coast of Martigues near the port of Marseille-Fos on January 25, 2026, as it’s surveilled by the French Navy. Thibaud Moritz | Afp | Getty Images President Donald Trump announced a U.S. trade deal with India on Monday […]

Read More
Ray Dalio warns the world is ‘on the brink’ of a capital war
World

Ray Dalio warns the world is ‘on the brink’ of a capital war

Ray Dalio, founder of Bridgewater Assoc., speaking on CNBC’s Squawk Box at the World Economic Forum in Davos, Switzerland on Jan. 20th, 2026. Oscar Molina | CNBC Legendary investor Ray Dalio warned on Tuesday that the world is “on the brink” of a capital war, amid simmering geopolitical tensions and volatile capital markets. Speaking to […]

Read More
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms
World

Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products.  But the company posted a modest 2026 outlook that fell short of Wall Street’s expectations as it prepares for a few drugs to lose patent protection later this year and face generic […]

Read More